WellPoint, Inc. is the largest publicly traded commercial health benefits company in terms of membership in the United States. WellPoint, Inc. is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, Nevada, New Hampshire, Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through HealthLink and UniCare.
HMOs, health maintenance organizations, offer managed healthcare services. Typically a member will pay a small co-payment to the doctor they visit, a doctor who must be a member of the HMO. The doctors are sometimes treated as partially financially responsible and therefore have the incentive to provide cost-effective healthcare. HMOs are like health insurance companies in that people pay a premium to the HMO company for its coverage.
|
| Totals |
Company |
Industry |
| Sales: |
$65,028.1 Mil |
$279,984.0 Mil |
| Market Cap: |
$23,704.2 Mil |
$111,119.7 Mil |
| Analysts Recommendation: |
Buy |
Buy |
|
|
| Averages |
Company |
Industry |
 |
| Growth |
| Historic Revenue: |
6.2% |
14.0% |
| Estimated Revenue: |
N/A |
N/A |
| Historic Earnings: |
11.1% |
36.9% |
| Estimated Earnings: |
17.3% |
23.8% |
| Stock Price (1 Year): |
19.1% |
22.4% |
| Cash per Share: |
144.9% |
48.0% |
| Dividend: |
N/A |
2,733.3% |
| Price |
| Trailing PE: |
9.2 |
20.8 |
| Forward PE: |
9.5 |
12.2 |
| Price-to-Sales: |
.4 |
N/A |
| Price-to-Book: |
1.4 |
2.0 |
| Dividend Yield: |
1.9% |
1.5% |
| Market Cap: |
$23,704.2 Mil |
$13,890.0 Mil |
| Operations |
| Net Margin: |
4.0% |
3.0% |
| Gross Margin: |
27.7% |
21.7% |
| Return on Equity: |
.2 |
.1 |
| Return on Assets: |
.1 |
.1 |
| Balance Sheet |
| Current Ratio: |
1.9 |
1.8 |
| Quick Ratio: |
1.9 |
1.8 |
| Cash Ratio: |
1.5 |
1.1 |
| Debt-to-Equity: |
1.1 |
1.2 |
| Interest Coverage: |
(.6) |
(1.2) |
| Technicals |
| Relative-Strength Index: |
68.2 |
N/A |
|
|
|
